Labor Day Was Last Monday - You Have Less Than 100 Working Days to Prepare for JP Morgan, Are You Ready?
It’s not too soon to start planning for the upcoming JP Morgan conference.
The JP Morgan Healthcare Conference is the probably the most important healthcare conference of the year. Companies from all over the world pay outrageous hotel room rates in order to setup meetings with investors, prospective partners, service providers, etc. A strong performance at JP Morgan lays the foundation for your company’s 2019.
Successful commercial products are the outcome most prospective investors and licensors want. And they are acutely aware that only 1/3 of new products developed and launched hit their pre-launch forecasts. Push back from payers on pricing is increasing and restricting product utilization and sales. They also know patients are beginning to balk at high co-payments, particularly as payers increasingly are not recognizing co-pay coupons for products not on formulary.
We’re Red Team Associates, a consulting firm that specializes in helping private, small, and mid-cap companies build a solid commercialization story and forecast to support their science and IP. We validate or re-validate the unmet need, the impact of new competitors, and help you demonstrate and monetize the value of your target product profile. Our forecasts are “bullet proof” because they’re built from the bottom-up vs top-down. Most importantly, we help you give investors and/or licensors the confidence needed for them to move forward with your company.
Red Team Associates are all highly experienced former C-suite client side executives.
- We know what investors and licensors look for because we’ve sat on the other side of the table for many years.
- Unlike many consulting firms claiming the same capabilities, our analyses are credible, backed by our over 100 years of experience and the more than 100 products we've helped develop and launch.
- All engagements are handled by our Managing Directors. We don’t fob off even the smallest client to junior level people.
- Without big offices and high overhead, we’re extremely cost effective.
- Though a boutique, we have a successful track record and references who can vouch for the quality and impact of our work.
With a solid commercial story to support your science, your company will “punch above its weight” at JPM. We welcome the opportunity to discuss how we can help you maximize your value and valuation.
______________________________
Harris Kaplan, Managing Director of Red Team Associates, has worked on the introduction of more than 100 new products including drug, biotech, device, and diagnostics, across more than 50 therapeutic categories. His extensive product development and commercialization experience and his keen understanding of how the shift from a provider to payer-dominated world impacts stakeholders have helped life sciences companies maximize the future value of product assets under development and on the market.
He has been a frequent speaker on the subject of innovation and new product development and his articles have appeared in In Vivo, Medical Marketing and Media, and Product Management. He is presenting at Intellus Worldwide Institute this coming October, and has presented at Windhover’s Therapeutic Area Partnerships, IN3 Device Conference, World Orphan Disease Conference, Life Science Alley, the Biotech Conference at UC Berkley, Pharmaceutical Strategy Conference, and the Drug Information Association.
Stay connected with him on LinkedIn
Harris Kaplan, Managing Partner
harris.kaplan@redteamassociates.com
410-215-9595